Kintegral Advisory’s Celgene CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Kintegral Advisory's CELG Position: Q4 2019 in Review
Kintegral Advisory sold out of Celgene (CELG) in Q4 2019, closing a stake of 17,299 shares — an estimated $1.72M sold.
Kintegral Advisory first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $1.72M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Kintegral Advisory reported no remaining Celgene position as of Q4 2019 after selling out during the quarter.
- Kintegral Advisory sold 17,299 Celgene shares in Q4 2019, an estimated $1.72M.
- Kintegral Advisory first reported a position in Celgene in Q4 2018 and held it in 4 quarters.
- Kintegral Advisory's Celgene position peaked at $1.72M in Q3 2019.
- 3 funds tracked by Wall St. Rank held Celgene as of Q4 2019.
Based on Kintegral Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.